Assure Holdings (Nasdaq:IONM) - Stock Price, News & Analysis

IONM Stock Overview

Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services in the United States.

About the company

IONM fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	0/6
Past Performance	0/6
Financial Health	2/6
Dividends	0/6

Rewards

Risk Analysis

Earnings have declined by 54.8% per year over past 5 years

Shareholders have been substantially diluted in the past year

Highly volatile share price over the past 3 months

Does not have a meaningful market cap ($8M)

+ 1 more risk

Assure Holdings Corp. Competitors

Optimus Healthcare Services

OTCPK:OHCS

US$3.5m

Greenbrook TMS

OTCPK:GBNH.F

US$3.0m

Interpace Biosciences

OTCPK:IDXG

US$6.4m

Invitae

OTCPK:NVTA.Q

US$2.6m

Price History & Performance

Summary of all time highs, changes and price drops for Assure Holdings
Historical stock prices
Current Share Price	US$0.89
52 Week High	US$4.17
52 Week Low	US$0.20
Beta	1.69
1 Month Change	99.60%
3 Month Change	304.09%
1 Year Change	-69.55%
3 Year Change	-99.35%
5 Year Change	-99.21%
Change since IPO	-99.11%

Recent updates

Assure Holdings stock gains on proposed public offering of common stock

Aug 22

Assure Holdings to continue streamlining business to achieve positive operating cash flow

Jul 14

Assure Holdings announces partnership with Hayden IR

Jul 06

Investors Are Unsure About Assure, But I Am Not

Feb 17

Shareholder Returns

	IONM	US Healthcare	US Market
7D	39.7%	0.6%	1.0%
1Y	-69.6%	2.2%	21.9%

Return vs Industry: IONM underperformed the US Healthcare industry which returned 3.4% over the past year.

Return vs Market: IONM underperformed the US Market which returned 24.9% over the past year.

Price Volatility

Is IONM's price volatile compared to industry and market?
IONM volatility
IONM Average Weekly Movement	21.7%
Healthcare Industry Average Movement	7.3%
Market Average Movement	6.0%
10% most volatile stocks in US Market	16.8%
10% least volatile stocks in US Market	3.0%

Stable Share Price: IONM's share price has been volatile over the past 3 months.

Volatility Over Time: IONM's weekly volatility (22%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

Founded	Employees	CEO	Website
n/a	127	John Farlinger	www.assureneuromonitoring.com

Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services in the United States. It offers services in the areas of neurosurgery, spine, cardiovascular, orthopedic, ear, nose, throat, and other surgical procedures. The company delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures.

Assure Holdings Corp. Fundamentals Summary

How do Assure Holdings's earnings and revenue compare to its market cap?
IONM fundamental statistics
Market cap	US$8.00m
Earnings (TTM)	-US$34.21m
Revenue (TTM)	US$10.76m

0.7x

P/S Ratio

-0.2x

P/E Ratio

Is IONM overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IONM income statement (TTM)
Revenue	US$10.76m
Cost of Revenue	US$15.26m
Gross Profit	-US$4.50m
Other Expenses	US$29.72m
Earnings	-US$34.21m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	-3.80
Gross Margin	-41.81%
Net Profit Margin	-317.92%
Debt/Equity Ratio	-221.9%

How did IONM perform over the long term?

See historical performance and comparison

IONM Stock Overview

Rewards

Risk Analysis

Assure Holdings Corp. Competitors

OTCPK:OHCS

US$3.5m

OTCPK:GBNH.F

US$3.0m

OTCPK:IDXG

US$6.4m

OTCPK:NVTA.Q

US$2.6m

Price History & Performance

Recent News & Updates

Assure Holdings Receives Notice from Nasdaq Due to Delinquency in the Timely Filing of the Annual Report on Form 10-K for the Fiscal Year Ended December 31, 2023 Under Nasdaq Listing Rule 5250(c)(1)

Assure Holdings Corp. announced delayed annual 10-K filing

Danam Health, Inc. entered into a definitive agreement and plan of merger to acquire Assure Holdings Corp. (NasdaqCM:IONM) in a reverse merger transaction.

Assure Holdings Corp. Announces to Appoint Suren Ajjarapu as Chairman

Assure Holdings Corp. Receives A Determination Letter from Listing Qualifications Staff of Nasdaq

Assure Holdings Receives Non-Compliance Notice from Nasdaq Regarding Non-Compliance with Nasdaq Listing Rule 5250(c)(1)

Recent updates

Assure Holdings Receives Notice from Nasdaq Due to Delinquency in the Timely Filing of the Annual Report on Form 10-K for the Fiscal Year Ended December 31, 2023 Under Nasdaq Listing Rule 5250(c)(1)

Assure Holdings Corp. announced delayed annual 10-K filing

Danam Health, Inc. entered into a definitive agreement and plan of merger to acquire Assure Holdings Corp. (NasdaqCM:IONM) in a reverse merger transaction.

Assure Holdings Corp. Announces to Appoint Suren Ajjarapu as Chairman

Assure Holdings Corp. Receives A Determination Letter from Listing Qualifications Staff of Nasdaq

Assure Holdings Receives Non-Compliance Notice from Nasdaq Regarding Non-Compliance with Nasdaq Listing Rule 5250(c)(1)

Assure Holdings Corp. announced delayed 10-Q filing

Nasdaq Grants an Extension of Time to Assure Holdings to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement

Assure Holdings Receives Non-Compliance Notice from Nasdaq Regarding Non-Compliance with $2.5 Million Stockholders’ Equity Requirement for Continued Listing on The Nasdaq Capital Market

Assure Holdings Receives Non-Compliance Notice From Nasdaq

Assure Holdings Corp. to Report Q2, 2023 Results on Aug 14, 2023

Assure Holdings Corp. (NasdaqCM:IONM) completed the acquisition of Certain Assets from Innovation Neuromonitoring, LLC for $1.2 million.

Assure Holdings Receives Letter from Nasdaq Regarding Non-Compliance with the Minimum Bid Price Requirement as Set Forth in Nasdaq Listing Rule 5550(a)(2)

Assure Holdings Corp. (NasdaqCM:IONM) signed a Letter of Intent to acquire Certain Assets from Innovation Neuromonitoring, LLC for $1.2 million.

Assure Holdings Corp. has completed a Follow-on Equity Offering in the amount of $6 million.

Assure Holdings Corp. Provides Revenue Guidance for the Fourth Quarter of 2022

Assure Holdings Corp., Annual General Meeting, Dec 28, 2022

Assure Holdings Corp. to Report Q3, 2022 Results on Nov 14, 2022

Assure Holdings Corp. Announces Executive Changes

Assure Holdings Receives Letter from the Listing Qualifications Staff of Nasdaq

Assure Holdings Corp. has completed a Follow-on Equity Offering in the amount of $6.245217 million.

Assure Holdings stock gains on proposed public offering of common stock

Assure Holdings Corp. to Report Q2, 2022 Results on Aug 15, 2022

Assure Holdings to continue streamlining business to achieve positive operating cash flow

Assure Holdings announces partnership with Hayden IR

Assure Holdings Corp. Provides Operational Guidance for the Year 2022

Assure Holdings Corp. to Report Q1, 2022 Results on May 16, 2022

Assure Holdings Corp. Appoints James Watt as National Technologist Director

Assure Holdings Corp. Announces Management Change

Investors Are Unsure About Assure, But I Am Not

Assure Announces Voluntary Delisting from TSX Venture Exchange

Assure Holdings Corp. announced that it has received $0.435157 million in funding

Assure Holdings Corp. announced that it expects to receive $0.435157 million in funding

Third quarter 2021 earnings released: EPS US$0.008 (vs US$0.14 loss in 3Q 2020)

Price target decreased to US$17.00

Assure Holdings Corp. announced that it expects to receive $11 million in funding from Centurion Financial Trust

Assure Holdings Corp. Raises Production Guidance for the Year 2021

Assure Holdings Corp. (TSXV:IOM) completed the acquisition of all assets of Sentry Neuromonitoring, LLC.

Assure Holdings Corp. Provides Production Guidance for the Year 2021

Assure Holdings Corp. Appoints Isador Lieberman to its Medical Advisory Committee

Assure Holdings Corp. (TSXV:IOM) signed a term sheet to acquire Sentry Neuromonitoring, LLC for $3.5 million.

Assure Holdings Corp. Adds New Surgeons to its Platform in Arizona

Assure Holdings Corp. announced that it has received $10.46893 million in funding from Manchester Management Company, LLC and other investors

Assure Holdings Corp. announced that it expects to receive $10.28096 million in funding

Assure Holdings Corp. to Report Q3, 2020 Results on Nov 30, 2020

Assure Holdings Corp. Promotes Craig Caviness to Vice President of Corporate Development from His Former Role as Eastern U.S. Territory Director

Assure Holdings Corp. announced that it expects to receive $0.0405 million in funding

Assure Holdings Corp. to Report Q2, 2020 Results on Aug 28, 2020

Assure Holdings Corp. announced a financing transaction

Assure Holdings Corp. to Report Q1, 2020 Results on Jul 14, 2020